The Bio Accelerationism (bio/acc) podcast. Deeply researched interviews about fascinating topics from biotech and research.
Podcast hosted by Shriya Bhat, a Harvard Sophomore from the Harvard Bioethics Communication Initiative (BCI).
Biotech CEO building an operating system for in vivo cell engineering -- Jay Rosanelli
Jay Rosanelli is the CEO and Co-Founder of Syenex, a biotech developing a platform for in vivo gene therapy delivery. While capital in the gene and cell therapy (CGT) space has grown over the last 5 years, there remain serious bottlenecks in delivery. In this conversation, we discuss what Syenex is building, the future of CGT, and what's next in AI-driven drug discovery and neurotech. Check out what Syenex is building: https://www.syenex.com/ 0:00 Introduction 0:55 Background 4:56 Biotech Capital 11:50 The Delivery Problem 17:37 Platform vs. Therapeutics 24:08 Partnership Model31:28 In-vivo CAR-T 37:49 Economics of Platform 42:08 AI x BIo 48:19 Future of BiotechABOUT MEHi, my name is Shriya; I'm a sophomore at Harvard and the host of the Bio/Acc Podcast. I started this podcast out of the Harvard Bioethics Communication Initiative to conduct deeply researched interviews with the world's most interesting people in biotech.Produced by @RishabJainSOCIAL LINKS:🎤 Listen on Spotify: https://open.spotify.com/episode/4m42...🎤 Listen on Apple: https://podcasts.apple.com/us/podcast...See our Website: https://bioacceleration.com/Connect w/ Shriya on Linkedin: www.linkedin.com/in/shriya-bhat-0b845b203Let us know what you think in the comments below! Subscribe to our channel for more podcasts.
17 Jan 2026
Biotech Director at DARPA on Bio Innovation in Warfare in the Age of AI -- Michael Koeris
Michael Koeris is the Director of the Biological Technologies Office at DARPA, where he leads some of America's most cutting-edge biological research programs for defense. In this conversation, we discuss how AI is transforming warfare and what DARPA is doing to prepare for biological threats that may exist in the near future.
23 Dec 2025
RNA Therapeutics Could Cure Cancer and End All Rare Diseases -- with Professor Jeff Coller
Professor Jeff Coller discusses how RNA biology breakthroughs paved the way for mRNA vaccines and future RNA medicines with host Shriya Bhat in an interview.
Who has been a guest on bio/acc Podcast
Names identified in recent episode analyses. Showing up to five guests.
Professor Jeff Coller
John Quain
Aubrey de Grey
Charles Brenner
James Sinka
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
YouTube views
15,255
Score snapshot 15 Sept 2025
Podcast Authority Score: 39 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
48
Social presence
0
YouTube
76
Engagement
0
Host of bio/acc Podcast?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
